Eye News and Research

Latest Eye News and Research

Mother’s obesity surgery may cause vitamin deficiencies in children

Biliopancreatic diversion surgery for morbid obesity is known to cause multiple vitamin deficiencies that may worsen during pregnancy. In the June issue of the Journal of AAPOS, the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus, a group of Australian clinicians report a child who was born blind as a result of Vitamin A deficiency caused by his mother's obesity surgery.

17 Jul 2010

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Next week the city of Philadelphia will host the 52nd annual meeting of the American Association of Physicists in Medicine (AAPM), the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology.

16 Jul 2010

Scientists discover gene mutation responsible for CDG

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, has discovered the gene mutation responsible for a condition in which eye and brain development is severely disrupted in affected infants.

16 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

Alcon selects Varicent for sales performance management solutions

Varicent Software Incorporated, the leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, announced today that it will provide its innovative solutions to Alcon, the world's largest eye-care company.

15 Jul 2010

Positive microplasmin Phase II trial results published in journal Retina

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that positive microplasmin Phase II trial results, evaluating the product for the nonsurgical treatment of vitreomacular adhesion, have been published in the July/August issue of the journal Retina.

15 Jul 2010

Intrinsically photosensitive Retinal Ganglion Cells help blind mice 'see'

It would make the perfect question for the popular television show "Are You Smarter than a 5th Grader:" What parts of the eye allow us to see?

15 Jul 2010

New myopia control technology for eye health benefits from Vision CRC

Scientists from the Vision Cooperative Research Centre in Australia have announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners – the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.

15 Jul 2010

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

The University of Michigan Hospitals and Health Centers have been ranked among the country's best hospitals, placing 14th overall for the second consecutive year by U.S. News & World Report magazine. This year, U-M was ranked in every specialty and those rankings went up in 11 of the 16 specialties.

15 Jul 2010

Phase 1/2 clinical study of bepotastine besilate nasal spray initiated for seasonal allergic rhinitis

ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.

14 Jul 2010

Tips for first-time moms to enjoy feeding moments with their baby

For a majority of first-time moms feeding their baby can be an emotional and stressful experience. New moms encountering these common, yet unexpected feeding challenges are not alone. A recent national survey, commissioned by Playtex®, revealed that 85 percent of first-time moms have experienced at least one feeding-related problem when caring for their new baby.

14 Jul 2010

Predictors of an Asian diabetes epidemic: A study

Experts believe diabetes will be the leading disease in Asia mainly because of the rise in consumption of junk and high calorie foods in this region of the world.

13 Jul 2010

Line of moisture absorber products available to eliminate dampness that enables mold to grow

The stifling humidity accompanying this summer's extreme temperatures increases the chance that homeowners will experience significant indoor humidity and moisture that may lead to musty odors, allergens, and mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

13 Jul 2010

Aggressive infection control measures stop spread of Acinetobacter baumannii at Dallas hospital

Rapid identification and aggressive infection control measures allowed a Dallas hospital to stop the spread of Acinetobacter baumannii, a type of bacteria that has become increasingly prevalent in healthcare facilities and is resistant to most antibiotics. The findings were presented today at the 37th Annual Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology.

13 Jul 2010

Ophthalmology professor receives $60,000 RPB award to research Sjogren's syndrome

Hui Shao, MD, PhD, associate professor of ophthalmology and visual sciences at the University of Louisville School of Medicine, has received a $60,000 Lew R. Wasserman Merit Award from the Research to Prevent Blindness (RPB) organization. The grant will help fund Shao's research of Sjogren's syndrome, a chronic autoimmune disease that targets the salivary and lacrimal glands - the glands that produce saliva and tears, respectively - resulting in dry mouth and dry eye symptoms.

13 Jul 2010

Examination of cellular construction of motion detector in brain of fly

What would be the point of holding a soccer world championship if we couldn't distinguish the ball from its background? Simply unthinkable! But then again, wouldn't it be fantastic if your favourite team's striker could see the movements of the ball in slow motion! Unfortunately, this advantage only belongs to flies.

13 Jul 2010

Silicon oil appears to protect vision in patients undergoing radiation therapy for ocular melanoma: Study

Eye cancer patients face an unenviable dilemma. They must enter treatment knowing that their surgeon's strategy to kill the deadly tumor with radiation may also sacrifice their eyesight.

13 Jul 2010

Educational psychologists use eye-tracking method for detecting lies

Shifty eyes long have been thought to signify a person's problem telling the truth. Now a group of University of Utah researchers are taking that old adage to a new level.

12 Jul 2010

pSivida submits MAA for Iluvien to UK MHRA

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.

8 Jul 2010

Alimera Sciences submits MAA for Iluvien to MHRA

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals has submitted a Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency in the United Kingdom for Iluvien (fluocinolone acetonide intravitreal insert).

8 Jul 2010